Annals of the American Thoracic Society · 2026
Supplemental Oxygen Use in Patients with COPD after the 2016 Implementation of the Medicare Competitive Bidding Program.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Duan Kevin I, Obara Emmi, Wong Edwin S, Liao Joshua M, Sabbatini Amber K, Donovan Lucas M, Feemster Laura C, Au David H
Аннотация
RATIONALE: The Medicare Competitive Bidding Program (CBP), a policy that reduces durable medical equipment reimbursement rates through a bidding process, was expanded nationwide in 2016. Lower bid-derived prices may affect supplemental oxygen access, but little is known about the 2016 policy impact.
OBJECTIVE: Evaluate the association between the 2016 implementation of CBP and supplemental oxygen use among patients with chronic obstructive pulmonary disease (COPD).
METHODS: We used fee-for-service Medicare data of beneficiaries with COPD enrolled between July 1, 2009 and June 30, 2017, to conduct a single-group interrupted time series analysis of the 2016 expansion of CBP.
MEASUREMENTS: Primary outcomes were measured at the ZIP-month, including the proportion of COPD beneficiaries with a new oxygen claim, and the proportion of COPD beneficiaries on supplemental oxygen that had oxygen claims discontinued.
MAIN RESULTS: CBP expansion was not associated with a change in the monthly proportion of new oxygen claims at policy implementation [-0.0084 percentage points (ppt); 95% confidence interval (CI) -0.024, 0.0077], but was associated with a small decrease in monthly trend afterwards (-0.0054 ppt; 95%CI -0.0078, -0.0032). For discontinuation of oxygen claims, CBP expansion was associated with a small increase in the monthly proportion of discontinuations at policy implementation (0.24 ppt; 95%CI 0.14, 0.35), but no change in the post-policy trend (0.010 ppt; 95%CI -0.0051, 0.026).
CONCLUSIONS: Medicare CBP nationwide expansion in 2016 was not associated with a clinically meaningful change in oxygen use among beneficiaries with COPD and do not support removal of supplemental oxygen from the CBP.
OBJECTIVE: Evaluate the association between the 2016 implementation of CBP and supplemental oxygen use among patients with chronic obstructive pulmonary disease (COPD).
METHODS: We used fee-for-service Medicare data of beneficiaries with COPD enrolled between July 1, 2009 and June 30, 2017, to conduct a single-group interrupted time series analysis of the 2016 expansion of CBP.
MEASUREMENTS: Primary outcomes were measured at the ZIP-month, including the proportion of COPD beneficiaries with a new oxygen claim, and the proportion of COPD beneficiaries on supplemental oxygen that had oxygen claims discontinued.
MAIN RESULTS: CBP expansion was not associated with a change in the monthly proportion of new oxygen claims at policy implementation [-0.0084 percentage points (ppt); 95% confidence interval (CI) -0.024, 0.0077], but was associated with a small decrease in monthly trend afterwards (-0.0054 ppt; 95%CI -0.0078, -0.0032). For discontinuation of oxygen claims, CBP expansion was associated with a small increase in the monthly proportion of discontinuations at policy implementation (0.24 ppt; 95%CI 0.14, 0.35), but no change in the post-policy trend (0.010 ppt; 95%CI -0.0051, 0.026).
CONCLUSIONS: Medicare CBP nationwide expansion in 2016 was not associated with a clinically meaningful change in oxygen use among beneficiaries with COPD and do not support removal of supplemental oxygen from the CBP.